Anavex Life Sciences Corp
COM NEW · CUSIP 003279730
1
institutional holders
210.8k
shares reported held*
$2.2mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $10.32.
Holders, Q3 2022
| Manager | Shares | Change |
|---|---|---|
| Knoll Capital Management, LLC 1.27% of their portfolio | 210.8k $2.2m | — |